GSK and ViiV Healthcare confirmed today that the US District Court for the District of Delaware upheld the validity of a patent covering the double combination of? lamivudine and abacavir (Epzicom?) and the triple combination of lamivudine, ...
Tags: GSK, ViiV, Lupin Generic, Trizivir Patent
ViiV Healthcare, HIV company established by GlaxoSmithKline and Pfizer, has announced the FDA approval of an integrase inhibitor, Tivicay (dolutegravir) 50mg tablets, for the treatment of HIV-1. Tivicay is indicated for use in combination ...
Tags: Viiv Healthcare, HIV-1
A combination of GlaxoSmithKline’s GSK744 and J&J’s TMC278 monthly injection therapy, designed to evaluate its potential to control HIV, is currently being tested. Results of a study, which was conducted on 40 HIV-negative ...
Tags: Injection Therapy, Medicine
The USFDA has granted priority review designation to ViiV Healthcare's dolutegravir as a candidate with the potential to treat HIV infection in combination with other antiretroviral agents, in adolescents and adults. The dolutegravir new ...
Tags: infection therapy, Healthcare, FDA
Aurobindo Pharma has won the final FDA approval to manufacture and market its generic anti-Human Immunodeficiency Virus (HIV) drug, Abacavir Tablets USP 300mg. Abacavir, the generic version of ViiV Healthcare Company's Ziagen Tablets ...
Tags: Anti-HIV Drug, FDA Nod, Aurobindo, Medicine